Global COPD Medication Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 42852
  • calendar_today Published On: Mar, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The COPD Medication market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global COPD Medication size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global COPD Medication market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

COPD Medication market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Short-Acting Bronchodilator

Corticosteroids

Methylxanthines

Long-Acting Bronchodilators

Combination Drugs

Market segment by Application, can be divided into

Hospital

Clinic

Pharmacy

Online Pharmacy

Market segment by players, this report covers

Roche

Novartis

GSK

Teva

AstraZeneca

Boehringer Ingelheim

Nephron Pharmaceuticals

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of COPD Medication

1.2 Classification of COPD Medication by Type

1.2.1 Overview: Global COPD Medication Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global COPD Medication Revenue Market Share by Type in 2020

1.2.3 Short-Acting Bronchodilator

1.2.4 Corticosteroids

1.2.5 Methylxanthines

1.2.6 Long-Acting Bronchodilators

1.2.7 Combination Drugs

1.3 Global COPD Medication Market by Application

1.3.1 Overview: Global COPD Medication Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Pharmacy

1.3.5 Online Pharmacy

1.4 Global COPD Medication Market Size & Forecast

1.5 Global COPD Medication Market Size and Forecast by Region

1.5.1 Global COPD Medication Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global COPD Medication Market Size by Region, (2016-2021)

1.5.3 North America COPD Medication Market Size and Prospect (2016-2026)

1.5.4 Europe COPD Medication Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific COPD Medication Market Size and Prospect (2016-2026)

1.5.6 South America COPD Medication Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa COPD Medication Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 COPD Medication Market Drivers

1.6.2 COPD Medication Market Restraints

1.6.3 COPD Medication Trends Analysis

2 Company Profiles

2.1 Roche

2.1.1 Roche Details

2.1.2 Roche Major Business

2.1.3 Roche COPD Medication Product and Solutions

2.1.4 Roche COPD Medication Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Roche Recent Developments and Future Plans

2.2 Novartis

2.2.1 Novartis Details

2.2.2 Novartis Major Business

2.2.3 Novartis COPD Medication Product and Solutions

2.2.4 Novartis COPD Medication Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Novartis Recent Developments and Future Plans

2.3 GSK

2.3.1 GSK Details

2.3.2 GSK Major Business

2.3.3 GSK COPD Medication Product and Solutions

2.3.4 GSK COPD Medication Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 GSK Recent Developments and Future Plans

2.4 Teva

2.4.1 Teva Details

2.4.2 Teva Major Business

2.4.3 Teva COPD Medication Product and Solutions

2.4.4 Teva COPD Medication Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Teva Recent Developments and Future Plans

2.5 AstraZeneca

2.5.1 AstraZeneca Details

2.5.2 AstraZeneca Major Business

2.5.3 AstraZeneca COPD Medication Product and Solutions

2.5.4 AstraZeneca COPD Medication Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 AstraZeneca Recent Developments and Future Plans

2.6 Boehringer Ingelheim

2.6.1 Boehringer Ingelheim Details

2.6.2 Boehringer Ingelheim Major Business

2.6.3 Boehringer Ingelheim COPD Medication Product and Solutions

2.6.4 Boehringer Ingelheim COPD Medication Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Boehringer Ingelheim Recent Developments and Future Plans

2.7 Nephron Pharmaceuticals

2.7.1 Nephron Pharmaceuticals Details

2.7.2 Nephron Pharmaceuticals Major Business

2.7.3 Nephron Pharmaceuticals COPD Medication Product and Solutions

2.7.4 Nephron Pharmaceuticals COPD Medication Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Nephron Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global COPD Medication Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 5 COPD Medication Players Market Share

3.2.2 Top 10 COPD Medication Players Market Share

3.2.3 Market Competition Trend

3.3 COPD Medication Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global COPD Medication Revenue and Market Share by Type (2016-2021)

4.2 Global COPD Medication Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global COPD Medication Revenue Market Share by Application (2016-2021)

5.2 COPD Medication Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America COPD Medication Revenue by Type (2016-2026)

6.2 North America COPD Medication Revenue by Application (2016-2026)

6.3 North America COPD Medication Market Size by Country

6.3.1 North America COPD Medication Revenue by Country (2016-2026)

6.3.2 United States COPD Medication Market Size and Forecast (2016-2026)

6.3.3 Canada COPD Medication Market Size and Forecast (2016-2026)

6.3.4 Mexico COPD Medication Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe COPD Medication Revenue by Type (2016-2026)

7.2 Europe COPD Medication Revenue by Application (2016-2026)

7.3 Europe COPD Medication Market Size by Country

7.3.1 Europe COPD Medication Revenue by Country (2016-2026)

7.3.2 Germany COPD Medication Market Size and Forecast (2016-2026)

7.3.3 France COPD Medication Market Size and Forecast (2016-2026)

7.3.4 United Kingdom COPD Medication Market Size and Forecast (2016-2026)

7.3.5 Russia COPD Medication Market Size and Forecast (2016-2026)

7.3.6 Italy COPD Medication Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific COPD Medication Revenue by Type (2016-2026)

8.2 Asia-Pacific COPD Medication Revenue by Application (2016-2026)

8.3 Asia-Pacific COPD Medication Market Size by Region

8.3.1 Asia-Pacific COPD Medication Revenue by Region (2016-2026)

8.3.2 China COPD Medication Market Size and Forecast (2016-2026)

8.3.3 Japan COPD Medication Market Size and Forecast (2016-2026)

8.3.4 South Korea COPD Medication Market Size and Forecast (2016-2026)

8.3.5 India COPD Medication Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia COPD Medication Market Size and Forecast (2016-2026)

8.3.7 Australia COPD Medication Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America COPD Medication Revenue by Type (2016-2026)

9.2 South America COPD Medication Revenue by Application (2016-2026)

9.3 South America COPD Medication Market Size by Country

9.3.1 South America COPD Medication Revenue by Country (2016-2026)

9.3.2 Brazil COPD Medication Market Size and Forecast (2016-2026)

9.3.3 Argentina COPD Medication Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa COPD Medication Revenue by Type (2016-2026)

10.2 Middle East & Africa COPD Medication Revenue by Application (2016-2026)

10.3 Middle East & Africa COPD Medication Market Size by Country

10.3.1 Middle East & Africa COPD Medication Revenue by Country (2016-2026)

10.3.2 Turkey COPD Medication Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia COPD Medication Market Size and Forecast (2016-2026)

10.3.4 UAE COPD Medication Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global COPD Medication Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global COPD Medication Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market COPD Medication Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global COPD Medication Revenue (USD Million) by Region (2016-2021)

Table 5. Global COPD Medication Revenue Market Share by Region (2021-2026)

Table 6. Roche Corporate Information, Head Office, and Major Competitors

Table 7. Roche Major Business

Table 8. Roche COPD Medication Product and Solutions

Table 9. Roche COPD Medication Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Novartis Corporate Information, Head Office, and Major Competitors

Table 11. Novartis Major Business

Table 12. Novartis COPD Medication Product and Solutions

Table 13. Novartis COPD Medication Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. GSK Corporate Information, Head Office, and Major Competitors

Table 15. GSK Major Business

Table 16. GSK COPD Medication Product and Solutions

Table 17. GSK COPD Medication Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Teva Corporate Information, Head Office, and Major Competitors

Table 19. Teva Major Business

Table 20. Teva COPD Medication Product and Solutions

Table 21. Teva COPD Medication Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. AstraZeneca Corporate Information, Head Office, and Major Competitors

Table 23. AstraZeneca Major Business

Table 24. AstraZeneca COPD Medication Product and Solutions

Table 25. AstraZeneca COPD Medication Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors

Table 27. Boehringer Ingelheim Major Business

Table 28. Boehringer Ingelheim COPD Medication Product and Solutions

Table 29. Boehringer Ingelheim COPD Medication Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Nephron Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 31. Nephron Pharmaceuticals Major Business

Table 32. Nephron Pharmaceuticals COPD Medication Product and Solutions

Table 33. Nephron Pharmaceuticals COPD Medication Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Global COPD Medication Revenue (USD Million) by Players (2019-2021)

Table 35. Global COPD Medication Revenue Share by Players (2019-2021)

Table 36. Breakdown of COPD Medication by Company Type (Tier 1, Tier 2 and Tier 3)

Table 37. COPD Medication Players Head Office, Products and Services Provided

Table 38. COPD Medication Mergers & Acquisitions in the Past Five Years

Table 39. COPD Medication New Entrants and Expansion Plans

Table 40. Global COPD Medication Revenue (USD Million) by Type (2016-2021)

Table 41. Global COPD Medication Revenue Share by Type (2016-2021)

Table 42. Global COPD Medication Revenue Forecast by Type (2021-2026)

Table 43. Global COPD Medication Revenue by Application (2016-2021)

Table 44. Global COPD Medication Revenue Forecast by Application (2021-2026)

Table 45. North America COPD Medication Revenue by Type (2016-2021) & (USD Million)

Table 46. North America COPD Medication Revenue by Type (2021-2026) & (USD Million)

Table 47. North America COPD Medication Revenue by Application (2016-2021) & (USD Million)

Table 48. North America COPD Medication Revenue by Application (2021-2026) & (USD Million)

Table 49. North America COPD Medication Revenue by Country (2016-2021) & (USD Million)

Table 50. North America COPD Medication Revenue by Country (2021-2026) & (USD Million)

Table 51. Europe COPD Medication Revenue by Type (2016-2021) & (USD Million)

Table 52. Europe COPD Medication Revenue by Type (2021-2026) & (USD Million)

Table 53. Europe COPD Medication Revenue by Application (2016-2021) & (USD Million)

Table 54. Europe COPD Medication Revenue by Application (2021-2026) & (USD Million)

Table 55. Europe COPD Medication Revenue by Country (2016-2021) & (USD Million)

Table 56. Europe COPD Medication Revenue by Country (2021-2026) & (USD Million)

Table 57. Asia-Pacific COPD Medication Revenue by Type (2016-2021) & (USD Million)

Table 58. Asia-Pacific COPD Medication Revenue by Type (2021-2026) & (USD Million)

Table 59. Asia-Pacific COPD Medication Revenue by Application (2016-2021) & (USD Million)

Table 60. Asia-Pacific COPD Medication Revenue by Application (2021-2026) & (USD Million)

Table 61. Asia-Pacific COPD Medication Revenue by Region (2016-2021) & (USD Million)

Table 62. Asia-Pacific COPD Medication Revenue by Region (2021-2026) & (USD Million)

Table 63. South America COPD Medication Revenue by Type (2016-2021) & (USD Million)

Table 64. South America COPD Medication Revenue by Type (2021-2026) & (USD Million)

Table 65. South America COPD Medication Revenue by Application (2016-2021) & (USD Million)

Table 66. South America COPD Medication Revenue by Application (2021-2026) & (USD Million)

Table 67. South America COPD Medication Revenue by Country (2016-2021) & (USD Million)

Table 68. South America COPD Medication Revenue by Country (2021-2026) & (USD Million)

Table 69. Middle East & Africa COPD Medication Revenue by Type (2016-2021) & (USD Million)

Table 70. Middle East & Africa COPD Medication Revenue by Type (2021-2026) & (USD Million)

Table 71. Middle East & Africa COPD Medication Revenue by Application (2016-2021) & (USD Million)

Table 72. Middle East & Africa COPD Medication Revenue by Application (2021-2026) & (USD Million)

Table 73. Middle East & Africa COPD Medication Revenue by Country (2016-2021) & (USD Million)

Table 74. Middle East & Africa COPD Medication Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. COPD Medication Picture

Figure 2. Global COPD Medication Revenue Market Share by Type in 2020

Figure 3. Short-Acting Bronchodilator

Figure 4. Corticosteroids

Figure 5. Methylxanthines

Figure 6. Long-Acting Bronchodilators

Figure 7. Combination Drugs

Figure 8. COPD Medication Revenue Market Share by Application in 2020

Figure 9. Hospital Picture

Figure 10. Clinic Picture

Figure 11. Pharmacy Picture

Figure 12. Online Pharmacy Picture

Figure 13. Global COPD Medication Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 14. Global COPD Medication Revenue and Forecast (2016-2026) & (USD Million)

Figure 15. Global COPD Medication Revenue Market Share by Region (2016-2026)

Figure 16. Global COPD Medication Revenue Market Share by Region in 2020

Figure 17. North America COPD Medication Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Europe COPD Medication Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Asia-Pacific COPD Medication Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. South America COPD Medication Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. COPD Medication Market Drivers

Figure 22. COPD Medication Market Restraints

Figure 23. COPD Medication Market Trends

Figure 24. Roche Recent Developments and Future Plans

Figure 25. Novartis Recent Developments and Future Plans

Figure 26. GSK Recent Developments and Future Plans

Figure 27. Teva Recent Developments and Future Plans

Figure 28. AstraZeneca Recent Developments and Future Plans

Figure 29. Boehringer Ingelheim Recent Developments and Future Plans

Figure 30. Nephron Pharmaceuticals Recent Developments and Future Plans

Figure 32. Global COPD Medication Revenue Share by Players in 2020

Figure 33. COPD Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 34. Global Top 3 Players COPD Medication Revenue Market Share in 2020

Figure 35. Global Top 10 Players COPD Medication Revenue Market Share in 2020

Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 37. Global COPD Medication Revenue Share by Type in 2020

Figure 38. Global COPD Medication Market Share Forecast by Type (2021-2026)

Figure 39. Global COPD Medication Revenue Share by Application in 2020

Figure 40. Global COPD Medication Market Share Forecast by Application (2021-2026)

Figure 41. North America COPD Medication Sales Market Share by Type (2016-2026)

Figure 42. North America COPD Medication Sales Market Share by Application (2016-2026)

Figure 43. North America COPD Medication Revenue Market Share by Country (2016-2026)

Figure 44. United States COPD Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 45. Canada COPD Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 46. Mexico COPD Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 47. Europe COPD Medication Sales Market Share by Type (2016-2026)

Figure 48. Europe COPD Medication Sales Market Share by Application (2016-2026)

Figure 49. Europe COPD Medication Revenue Market Share by Country (2016-2026)

Figure 50. Germany COPD Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. France COPD Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. United Kingdom COPD Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. Russia COPD Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Italy COPD Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Asia-Pacific COPD Medication Sales Market Share by Type (2016-2026)

Figure 56. Asia-Pacific COPD Medication Sales Market Share by Application (2016-2026)

Figure 57. Asia-Pacific COPD Medication Revenue Market Share by Region (2016-2026)

Figure 58. China COPD Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Japan COPD Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. South Korea COPD Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. India COPD Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Southeast Asia COPD Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Australia COPD Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. South America COPD Medication Sales Market Share by Type (2016-2026)

Figure 65. South America COPD Medication Sales Market Share by Application (2016-2026)

Figure 66. South America COPD Medication Revenue Market Share by Country (2016-2026)

Figure 67. Brazil COPD Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Argentina COPD Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Middle East and Africa COPD Medication Sales Market Share by Type (2016-2026)

Figure 70. Middle East and Africa COPD Medication Sales Market Share by Application (2016-2026)

Figure 71. Middle East and Africa COPD Medication Revenue Market Share by Country (2016-2026)

Figure 72. Turkey COPD Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Saudi Arabia COPD Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. UAE COPD Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Methodology

Figure 76. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

+1

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketquest.biz